Enjoy complimentary customisation on priority with our Enterprise License!
The Germany pharmaceuticals market size is estimated to grow by USD 21.44 billion between 2022 and 2027. The market size is forecast to grow at a CAGR of 6.25%. The growth of the market depends on several factors, including high investment in the pharmaceutical industry, an increasing geriatric population, and a growing number of M&As.
To learn more about this report, View Report Sample
The high investment in the pharmaceutical industry is notably driving the market growth, although factors such as the system of pricing and reimbursement may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The high investment in the pharmaceutical industry is notably driving the Pharmaceutical market growth in Germany. Germany has a robust and highly regarded pharmaceutical industry, with several major pharmaceutical companies operating there. Germany's strong R&D capacity, experienced workforce, and high-quality healthcare system are helping the industry. In recent years, Germany has been a major location for investment in pharmaceuticals.
Companies invest in various aspects of the industry, including research and development (R and D), manufacturing facilities, distribution networks, and marketing. The funds will be used for the development of innovative technologies, new production facilities and digitalization. Thus, high investment by major players will boost the growth of the pharmaceutical market in Germany during the forecast period.
Robust growth of e-commerce is a primary trend in the market. E-commerce has significantly impacted the market, transforming how people access and purchase medications. E-commerce has made it easier for consumers to access pharmaceutical products from the comfort of their homes. With the convenient ordering of prescriptions and over-the-counter drugs through internet pharmacies and health platforms, customers are provided with a variety of medicines and healthcare products. In comparison to conventional brick-and-mortar pharmacies, e-pharmacies like Pharm Easy offer a wider range of products.
Moreover, E-commerce allows consumers to make a simple comparison of prices from several pharmacies on the Internet. It has led to a greater degree of price transparency and competition, reducing prices and offering potential savings for customers. Online pharmacies can reach customers nationwide, even in areas with limited physical pharmacy infrastructure. This increased medication access has improved healthcare outcomes for people, which will increase the market growth during the forecast period.
The market report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Market Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Abbott Laboratories: The company offers pharmaceuticals such as Amplatzer, Gallant, and Endurity.
The research report also includes detailed analyses of the competitive landscape of the market and information about 15 market players, including:
Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.
The market share growth by the pharmacy segment will be significant during the forecast period. The demand for prescription medicine in Germany is influenced by several factors, including the country's aging population, the prevalence of chronic diseases, and advancements in medical treatments. Germany has a comprehensive healthcare system that allows its citizens to take advantage of prescription medicines.
Get a glance at the market contribution of various segments View the PDF Sample
The pharmacy segment shows a gradual increase in the market share of USD 41.24 billion in 2017 and continued to grow by 2021. Germany has a strong pharmaceutical industry known for its research and development activities. The country has many national and foreign pharmaceutical firms producing a wide range of medicinal products for patients. This availability of medications contributes to the demand for pharmaceutical products such as medicines and vaccines in Germany.
The market report forecasts market growth by revenue and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
The Market, within the Federal Republic of Germany, exhibits significant activity in research and development, evident from its Phase III clinical trials and R&D pipeline. Notable drugs include Empagliflozin and Nintedanib for conditions like diabetes and lung diseases. The market addresses cancer treatment with drugs like Nubeqa for prostate cancer. It also focuses on combating diseases such as breast, lung, and prostate cancer, with innovative medications like Androgen Receptor inhibitors. Additionally, advancements in pharmaceutical formulations, including solid formulations, biosimilars, and generic drugs, contribute to market growth, alongside the presence of key players like STADA AG and Bausch Health Companies Inc.
Germany Pharmaceuticals Market Scope |
|
Report Coverage |
Details |
Page number |
124 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 6.25% |
Market growth 2023-2027 |
USD 21.44 billion |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
5.58 |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
Abbott Laboratories, AbbVie Inc., Amgen Inc., AstraZeneca, Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb, Eli Lilly and Co., F. Hoffmann La Roche Ltd., Fresenius SE and Co. KGaA, GlaxoSmithKline Plc, Johnson and Johnson Services Inc., MCM Klosterfrau Vertriebsgesellschaft mbH, Merck KGaA, Novartis AG, Novo Nordisk AS, Pfizer Inc., Sanofi, STADA Arzneimittel AG, and Teva Pharmaceutical Industries Ltd. |
Market dynamics |
Parent market analysis, Market forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period. |
Customization purview |
If our market growth and trends market analysis and report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Distribution Channel
7 Market Segmentation by Type
8 Customer Landscape
9 Drivers, Challenges, and Trends
10 Vendor Landscape
11 Vendor Analysis
12 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.